AT307380B - Verfahren zur Herstellung von neuen Aminoalkyladamantanen und deren Säureadditionssalzen - Google Patents
Verfahren zur Herstellung von neuen Aminoalkyladamantanen und deren SäureadditionssalzenInfo
- Publication number
- AT307380B AT307380B AT817269A AT817269A AT307380B AT 307380 B AT307380 B AT 307380B AT 817269 A AT817269 A AT 817269A AT 817269 A AT817269 A AT 817269A AT 307380 B AT307380 B AT 307380B
- Authority
- AT
- Austria
- Prior art keywords
- aminoalkyladamantanes
- preparation
- new
- acid addition
- addition salts
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/132—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings
- C07C53/136—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings containing condensed ring systems
- C07C53/138—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings containing condensed ring systems containing an adamantane ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/38—Acyl halides
- C07C53/44—Acyl halides containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/36—Acyl halides
- C07C55/38—Acyl halides containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Catalysts (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pivots And Pivotal Connections (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB40968/68A GB1274652A (en) | 1968-08-27 | 1968-08-27 | Adamantanyl-alkylamine derivatives and their preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AT307380B true AT307380B (de) | 1973-05-25 |
Family
ID=10417493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT817269A AT307380B (de) | 1968-08-27 | 1969-08-26 | Verfahren zur Herstellung von neuen Aminoalkyladamantanen und deren Säureadditionssalzen |
Country Status (12)
| Country | Link |
|---|---|
| JP (3) | JPS5010856B1 (de) |
| AT (1) | AT307380B (de) |
| BE (1) | BE737975A (de) |
| CH (3) | CH538442A (de) |
| DE (1) | DE1943404A1 (de) |
| DK (1) | DK131721C (de) |
| FR (1) | FR2016468B1 (de) |
| GB (1) | GB1274652A (de) |
| IE (1) | IE33929B1 (de) |
| IL (1) | IL32892A (de) |
| NL (1) | NL6913046A (de) |
| SE (1) | SE364037B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS507356A (de) * | 1973-05-22 | 1975-01-25 | ||
| GB0013737D0 (en) | 2000-06-07 | 2000-07-26 | Astrazeneca Ab | Novel compounds |
| SE0103836D0 (sv) * | 2001-11-16 | 2001-11-16 | Astrazeneca Ab | Novel compounds |
| SE0300480D0 (sv) | 2003-02-21 | 2003-02-21 | Astrazeneca Ab | Novel compounds |
| GB0312609D0 (en) | 2003-06-02 | 2003-07-09 | Astrazeneca Ab | Novel compounds |
| ITTO20030668A1 (it) | 2003-09-02 | 2005-03-03 | Rotta Res Lab S P A O Ra Rottapharm | Derivati dell'adamantano dotati di attivita' neuroprotettiva, antidepressiva e anti-ischemica e procedimento per la loro preparazione. |
| PE20091225A1 (es) | 2007-03-22 | 2009-09-16 | Astrazeneca Ab | Derivados de quinolina como antagonistas del receptor p2x7 |
| PE20091036A1 (es) | 2007-11-30 | 2009-08-15 | Astrazeneca Ab | Derivado de quinolina como antagonista del receptor p2x7 |
| CN109593042B (zh) * | 2018-12-24 | 2021-12-07 | 陕西莱特迈思光电材料有限公司 | 一种有机电致发光材料及包含其的有机电致发光器件 |
| CN114181091B (zh) * | 2021-12-27 | 2024-06-14 | 维思普新材料（苏州）有限公司 | 一种金刚烷三苯胺的合成工艺 |
| CN116947644B (zh) * | 2023-07-26 | 2025-01-24 | 山东轩鸿生物医药有限公司 | 一种盐酸美金刚的制备方法 |
-
1968
- 1968-08-27 GB GB40968/68A patent/GB1274652A/en not_active Expired
-
1969
- 1969-08-25 IL IL6932892A patent/IL32892A/he unknown
- 1969-08-26 DE DE19691943404 patent/DE1943404A1/de active Pending
- 1969-08-26 SE SE11809/69A patent/SE364037B/xx unknown
- 1969-08-26 CH CH1300669A patent/CH538442A/fr not_active IP Right Cessation
- 1969-08-26 NL NL6913046A patent/NL6913046A/xx unknown
- 1969-08-26 BE BE737975A patent/BE737975A/xx unknown
- 1969-08-26 CH CH143372A patent/CH553149A/fr not_active IP Right Cessation
- 1969-08-26 CH CH1435971A patent/CH551365A/fr not_active IP Right Cessation
- 1969-08-26 AT AT817269A patent/AT307380B/de active
- 1969-08-26 DK DK457869A patent/DK131721C/da active
- 1969-08-27 FR FR696929356A patent/FR2016468B1/fr not_active Expired
- 1969-08-27 IE IE1170/69A patent/IE33929B1/xx unknown
-
1972
- 1972-06-29 JP JP47064561A patent/JPS5010856B1/ja active Pending
- 1972-06-29 JP JP47064562A patent/JPS4939256B1/ja active Pending
- 1972-06-29 JP JP47064563A patent/JPS4939257B1/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DK131721B (da) | 1975-08-25 |
| DE1943404A1 (de) | 1970-12-17 |
| DK131721C (da) | 1976-01-26 |
| CH553149A (fr) | 1974-08-30 |
| GB1274652A (en) | 1972-05-17 |
| CH538442A (fr) | 1973-06-30 |
| FR2016468B1 (de) | 1973-06-08 |
| IL32892A (en) | 1975-04-25 |
| IE33929B1 (en) | 1974-12-11 |
| IE33929L (en) | 1970-02-27 |
| JPS4939256B1 (de) | 1974-10-24 |
| FR2016468A1 (de) | 1970-05-08 |
| JPS5010856B1 (de) | 1975-04-24 |
| NL6913046A (de) | 1970-03-03 |
| JPS4939257B1 (de) | 1974-10-24 |
| IL32892A0 (en) | 1969-11-12 |
| BE737975A (de) | 1970-02-26 |
| SE364037B (de) | 1974-02-11 |
| CH551365A (fr) | 1974-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT292678B (de) | Verfahren zur Herstellung von neuen 1-Phenoxy-2-hydroxy-3-alkylaminopropanen und von deren Säureadditionssalzen | |
| AT305244B (de) | Verfahren zur Herstellung von neuen substituierten 1-Phenoxy-2-hydroxy-3-alkylaminopropanen und von deren Säureadditionssalzen | |
| AT307380B (de) | Verfahren zur Herstellung von neuen Aminoalkyladamantanen und deren Säureadditionssalzen | |
| AT273076B (de) | Verfahren zur Herstellung von neuen Phenoxypropylaminen und deren Säureadditionssalzen | |
| AT293419B (de) | Verfahren zur Herstellung von neuen 1-Carbamyl-3-phenylpyrrolidinen und deren Säureadditionssalzen | |
| AT296252B (de) | Verfahren zur Herstellung von neuen N-Acyl-hydroxylaminderivaten und deren Säureadditionssalzen | |
| AT321265B (de) | Verfahren zur Herstellung von neuen Benzobicycloalkanaminen und deren Säureadditionssalzen | |
| AT294095B (de) | Verfahren zur Herstellung von neuen 6,7-Diacyloxytetrahydroisochinolin-Verbindungen und von deren Säureadditionssalzen | |
| AT302994B (de) | Verfahren zur Herstellung von neuen N-Aminoäthoxyacetyl-aminoadamantanen und deren Säureadditionssalzen | |
| AT298495B (de) | Verfahren zur Herstellung von neuen Diallylaminoalkanoylamiden und von deren Säureadditionssalzen | |
| AT289106B (de) | Verfahren zur Herstellung von neuen 1-Pyridyl-2-imidazolonen und deren Säureadditionssalzen | |
| AT307385B (de) | Verfahren zur Herstellung von neuen 1-Acylaminoalkylphenoxy-2-hydroxy-3-alkylaminopropanen und von deren Säureadditionssalzen | |
| AT294845B (de) | Verfahren zur Herstellung von neuen Nitrofuryl-aminoalkoxy-pyrimidinen und deren Salzen | |
| AT305250B (de) | Verfahren zur Herstellung von neuen 1-Hydroxyphenyl-1-hydroxy-2-(3-aryl-3-hydroxypropyl)-aminoäthanen und von deren Säureadditionssalzen | |
| AT294797B (de) | Verfahren zur Herstellung der neuen N-Propionyl-ɛ-aminocapronsäure und von deren Salzen | |
| AT305246B (de) | Verfahren zur Herstellung von neuen substituierten 1-Phenoxy-2-hydroxy-3-aminopropanen und von deren Säureadditionssalzen | |
| AT289092B (de) | Verfahren zur Herstellung von neuen Aminobenzocycloalkylnitrilen und deren Salzen | |
| AT318556B (de) | Verfahren zur Herstellung von neuen 2-Aminobornanen und von deren Säureadditionssalzen | |
| AT309397B (de) | Verfahren zur Herstellung von neuen tricyclischen Aminoketonen und von deren Säureadditionssalzen | |
| AT276375B (de) | Verfahren zur Herstellung von neuen 1-Aminoalkyl-thiophthalanen und deren Säureadditionssalzen | |
| AT318646B (de) | Verfahren zur Herstellung von neuen Acylaminoäthylbenzolsulfonylharnstoffen und von deren Salzen | |
| AT308720B (de) | Verfahren zur Herstellung von neuen substituierten N-Phenylthioalkyl-phenylalkanolaminen und von deren Säureadditionssalzen | |
| AT312617B (de) | Verfahren zur Herstellung von neuen 2-Amino-dihydro-benzodiazepinonen und deren Säureadditionssalzen | |
| AT296309B (de) | Verfahren zur Herstellung von neuen Tetrahydropyridinderivaten und deren Säureadditionssalzen | |
| AT310721B (de) | Verfahren zur Herstellung von neuen N-Phenylthioalkyl-phenylalkanolaminen und von deren Säureadditionssalzen |